IL6 and Alzheimer disease: Although there is evidence that both IL-6 and NfL contribute to neurodegeneration, the relationship with AD pathology is more consistent for NfL than IL-6, likely given IL-6 complex interactions with other inflammatory markers and receptor polymorphisms.